{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:06:44Z","timestamp":1783620404788,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>While pulmonary ILC2s represent one of the major tissue-resident innate lymphoid cell populations at steady state and are key drivers of cytokine secretion in their occupational niche, their role in pulmonary cancer progression remains unclear. As the programmed cell death protein-1 (PD-1) plays a major role in cancer immunotherapy and immunoregulatory properties, here we investigate the specific effect of PD-1 inhibition on ILC2s during pulmonary B16 melanoma cancer metastasis. We demonstrate that PD-1 inhibition on ILC2s suppresses B16 tumor growth. Further, PD-1 inhibition upregulates pulmonary ILC2-derived TNF-\u03b1 production, a cytotoxic cytokine that directly induces cell death in B16 cells, independent of adaptive immunity. Together, these results highlight the importance of ILC2s and their anti-tumor role in pulmonary B16 cancer progression during PD-1 inhibitory immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2021.733136","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:56:51Z","timestamp":1630706211000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-\u03b1 Production and Restricts Progression of Metastatic Melanoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Emily","family":"Howard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Hurrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doumet Georges","family":"Helou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Shafiei-Jahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parkash S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Soroosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene H.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-005-0002-5","article-title":"Treatment of Metastatic Malignant Melanoma","volume":"6","author":"Atallah","year":"2005","journal-title":"Curr Treat Options Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4065\/81.4.511","article-title":"Metastatic Malignant Melanoma of the Gastrointestinal Tract","volume":"81","author":"Liang","year":"2006","journal-title":"Mayo Clinic Proc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.37","article-title":"From Melanocytes to Melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12935-020-01616-x","article-title":"Molecular Interaction and Cellular Studies on Combination Photodynamic Therapy With Rutoside for Melanoma A375 Cancer Cells: An In Vitro Study","volume":"20","author":"Khorsandi","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.05.073","article-title":"Astragalus Membranaceus Polysaccharides Potentiate the Growth-Inhibitory Activity of Immune Checkpoint Inhibitors Against Pulmonary Metastatic Melanoma in Mice","volume":"182","author":"Hwang","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.10.022","article-title":"Metastatic Melanoma Imaging Using a Novel Tc-99m-Labeled Lactam-Cyclized Alpha-MSH Peptide","volume":"27","author":"Liu","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00910","article-title":"Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions","volume":"10","author":"Mariotti","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1038\/s41467-020-17813-1","article-title":"PD-1 Pathway Regulates ILC2 Metabolism and PD-1 Agonist Treatment Ameliorates Airway Hyperreactivity","volume":"11","author":"Helou","year":"2020","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.542818","article-title":"Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity","volume":"11","author":"Hurrell","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.007","article-title":"ICOS:ICOS-Ligand Interaction is Required for Type 2 Innate Lymphoid Cell Function, Homeostasis, and Induction of Airway Hyperreactivity","volume":"42","author":"Maazi","year":"2015","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601421","article-title":"Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells","volume":"198","author":"Zhang","year":"2017","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","article-title":"IL-1\u03b2, IL-23, and TGF-\u03b2 Drive Plasticity of Human ILC2s Towards IL-17-Producing ILCs in Nasal Inflammation","volume":"10","author":"Golebski","year":"2019","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3447","article-title":"IL-1 Is a Critical Regulator of Group 2 Innate Lymphoid Cell Function and Plasticity","volume":"17","author":"Ohne","year":"2016","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3444","article-title":"IL-1\u03b2, IL-4 and IL-12 Control the Fate of Group 2 Innate Lymphoid Cells in Human Airway Inflammation in the Lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jaci.2020.08.024","article-title":"IL-10 Production by ILC2s Requires Blimp-1 and Cmaf, Modulates Cellular Metabolism, and Ameliorates Airway Hyperreactivity","volume":"147","author":"Howard","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170051","article-title":"ILC2s Regulate Adaptive Th2 Cell Functions via PD-L1 Checkpoint Control","volume":"214","author":"Schwartz","year":"2017","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161653","article-title":"PD-1 Regulates KLRG1+ Group 2 Innate Lymphoid Cells","volume":"214","author":"Taylor","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxs098","article-title":"PD-1 Is a Novel Regulator of Human B-Cell Activation","volume":"25","author":"Thibult","year":"2013","journal-title":"Int Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 Signaling in Primary T Cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.3390\/cancers12113285","article-title":"The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2210","article-title":"Targeting Tumor Vasculature With TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination With Adoptive Cell Therapy","volume":"24","author":"Elia","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101877","article-title":"Targeting TNF-\u03b1 to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy","volume":"188","author":"Calcinotto","year":"2012","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1158\/1078-0432.CCR-18-1728","article-title":"Antibody-Based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine","volume":"25","author":"Probst","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aar3451","article-title":"Tumor Immune Evasion Arises Through Loss of TNF Sensitivity","volume":"3","author":"Kearney","year":"2018","journal-title":"Sci Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmet.2018.05.012","article-title":"Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-\u03b1-Dependent Intensification of Oxidative Stress and Tumor Cell Death","volume":"28","author":"Habtetsion","year":"2018","journal-title":"Cell Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5064","article-title":"PD-1 Regulates Self-Reactive CD8+ T Cell Responses to Antigen in Lymph Nodes and Tissues","volume":"179","author":"Keir","year":"2007","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.05.042","article-title":"LAIR-1 Acts as an Immune Checkpoint on Activated ILC2s and Regulates the Induction of Airway Hyperreactivity","author":"Helou","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1016\/j.celrep.2019.11.102","article-title":"TNFR2 Signaling Enhances ILC2 Survival, Function, and Induction of Airway Hyperreactivity","volume":"29","author":"Hurrell","year":"2019","journal-title":"Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2015-4","article-title":"ILC2s Amplify PD-1 Blockade by Activating Tissue-Specific Cancer Immunity","volume":"579","author":"Moral","year":"2020","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e6054706","DOI":"10.1155\/2017\/6054706","article-title":"Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model","volume":"2017","author":"Ishikawa","year":"2017","journal-title":"Evidence-Based Complement Alternat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122375","article-title":"Molecular Mechanisms of IL-33\u2013Mediated Stromal Interactions in Cancer Metastasis","volume":"3","author":"Andersson","year":"2018","journal-title":"JCI Insight"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000498857","article-title":"IL-33\/ST2 Axis Regulates Vasculogenic Mimicry via ERK1\/2-MMP-2\/9 Pathway in Melanoma","volume":"235","author":"Yang","year":"2019","journal-title":"DRM"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41467-017-00678-2","article-title":"Tumour-Derived PGD2 and NKp30-B7H6 Engagement Drives an Immunosuppressive ILC2-MDSC Axis","volume":"8","author":"Trabanelli","year":"2017","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41590-020-0745-y","article-title":"ILC2-Driven Innate Immune Checkpoint Mechanism Antagonizes NK Cell Anti-Metastatic Function in the Lung","volume":"21","author":"Schuijs","year":"2020","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1317420","DOI":"10.1080\/2162402X.2017.1317420","article-title":"IL-33 Restricts Tumor Growth and Inhibits Pulmonary Metastasis in Melanoma-Bearing Mice Through Eosinophils","volume":"6","author":"Lucarini","year":"2017","journal-title":"OncoImmunology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms19061813","article-title":"Lead (Pb) Exposure Enhances Expression of Factors Associated With Inflammation","volume":"19","author":"Metryka","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jaci.2016.06.032","article-title":"Human Circulating Group 2 Innate Lymphoid Cells can Express CD154 and Promote IgE Production","volume":"139","author":"Maggi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100370","article-title":"NK Cell-Depleting Anti-Asialo GM1 Antibody Exhibits a Lethal Off-Target Effect on Basophils In Vivo","volume":"186","author":"Nishikado","year":"2011","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.733136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:56:53Z","timestamp":1630706213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.733136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2021.733136"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.733136","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"article-number":"733136"}}